EMEA-000191-PIP01-08-M05
Key facts
Invented name |
Vfend
|
Active substance |
voriconazole
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0151/2013
|
PIP number |
EMEA-000191-PIP01-08-M05
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
|
Contact for public enquiries |
Pfizer Limited
|
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Compliance procedure number |
EMEA-C-000191-PIP01-08-M05
|
Compliance opinion date |
09/08/2013
|
Compliance outcome |
positive
|